M C Meyer

Drug Product Selection--Part 2: Scientific basis of bioavailability and bioequivalence testing.

M C Meyer, 1991, American pharmacy.

Relating formulation variables to in vitro dissolution using an artificial neural network.

M C Meyer, N K Ebube, T McCall, 1997, Pharmaceutical development and technology.

Pharmacokinetics of chlorpheniramine, phenytoin, glipizide and nifedipine in an individual homozygous for the CYP2C9*3 allele.

M C Meyer, J. Goldstein, A. Straughn, 1999, Pharmacogenetics.

The application of an artificial neural network and pharmacokinetic simulations in the design of controlled-release dosage forms.

M C Meyer, M. Meyer, Y. Chen, 1999, Journal of controlled release : official journal of the Controlled Release Society.

Phenytoin I: in vitro-in vivo correlation for 100-mg phenytoin sodium capsules.

M C Meyer, V. Shah, M. Meyer, 1983, Journal of pharmaceutical sciences.

Carbamazepine level‐A in vivo–in vitro correlation (IVIVC): a scaled convolution based predictive approach

M C Meyer, P Veng-Pedersen, J. Gobburu, 2000, Biopharmaceutics & drug disposition.